Live and On-Demand Events

The Emerging 2026 US and EU Chemical Policy Agendas

February 4, 2026 | Available On Demand

Julia John, MS, Scott Stephens, MPA, Xiaolu Wang, Esq.

We’re just days into 2026, and already major policy announcements impacting chemical regulation have come out or are on the horizon, including new EPA rules and guidance under TSCA and FIFRA and the EU’s REACH revision proposal. Join AgencyIQ by POLITICO’s chemicals research team on Wednesday, February 4, at 12:00pm ET for a lively, informative, and actionable webinar exploring the latest regulatory changes affecting the U.S. and EU chemicals sectors. We’ll explore important new regulations, requirements, policy developments, and anticipated actions as we kick off the new year. Plus, our experts will be on hand to answer your questions live.

Emerging State Food Policy Developments in 2026

January 27, 2026 | Available On Demand

Jared Rothstein, Scarlett Salem, MPH, MS, Alexander Gaffney, MS, RAC

We’re only a few days into 2026, and state activity is already accelerating with new policies and proposals that could reshape food regulation. Join AgencyIQ by POLITICO’s food research team on Tuesday, January 27 at 12:00pm ET for a lively, informative, and actionable webinar exploring what the growing state food policy patchwork will look like in 2026. Our experts will break down the latest state legislative proposals, upcoming regulatory requirements, and forecasted policy actions—highlighting key trends and what they mean for stakeholders. Plus, attendees will also have the opportunity to ask questions and get real-time insights from our team during a live Q&A.

Chemicals Update: State Regulatory Activity in 2025

December 17, 2025 | Available On Demand

Julia John, MS, Nathaniel Gajasa, Esq., Jared Rothstein

This year, states have accelerated the establishment of policies and programs to regulate chemicals amid slow action, deregulation, and uncertainty at the federal level. The impacts are wide ranging, affecting many sectors including chemical manufacturing as well as consumer goods and packaging.
 
For regulatory professionals, the regulatory patchwork is increasingly challenging as more states take matters into their own hands.
 
Join AgencyIQ’s regulatory experts for a lively and informative webinar focused on the latest state-level policies and regulations impacting the chemicals space, including:

• Safer consumer products program developments
• Extended producer responsibility requirements
• PFAS reporting and product prohibitions
• Other state chemical bans and requirements
 
We’ll discuss the state developments and trends that matter heading into 2026. Plus, we’ll be answering our attendees’ questions live.

Food Forecast: What FDA Has in Store Heading into 2026

December 16, 2025 | AVAILABLE ON-DEMAND

Jared Rothstein, Scarlett Salem, MS, MPH, Alexander Gaffney, MS, RAC

With the federal government shutdown now over and FDA funded for the full fiscal year, the agency is poised to accelerate its regulatory activity in the year ahead.

Join AgencyIQ’s regulatory experts on December 16, for a lively, insight-packed webinar exploring what FDA still has left on its 2025 regulatory policy agenda and what will likely be a priority for the agency heading into 2026, including:

• New regulatory obligations and deadlines under the Ag-FDA funding bill,
• The outlook for the updated U.S. Dietary Guidelines for Americans,
• The FDA’s evolving approach to the regulation of ultra-processed foods,
• Anticipated action on food allergen regulation, and
• Progress toward a phaseout of synthetic food dyes.

Our experts will share forecasts on agency actions, legislative initiatives, expected guidance documents, and more. Plus, we’ll take your questions live.

Food Regulatory Update: FDA’s Food Policies and Outlook

October 15, 2025 | AVAILABLE ON-DEMAND

Jared Rothstein, Alexander Gaffney, John Herlihy

Food regulation policy is transforming at a pace not seen in years. For food regulatory professionals, keeping up with the latest developments is tough enough, but understanding the impacts of these policy developments is even more challenging. Luckily, AgencyIQ by POLITICO is here to help you see more and understand more.

Join AgencyIQ’s regulatory experts for a lively, informative and actionable webinar focused on the latest developments in food regulatory policy, including:
• The latest developments on the regulation of ultra-processed foods,
• State-level interest in food reforms,
• The current state of FDA and state government efforts to restrict food dyes,
• Federal interest in reforming the GRAS process, and
• What may be on the horizon following the release of the MAHA strategy

We’ll discuss the latest policies, major actions, trends, forecasted actions and political developments that matter to food regulatory professionals. Plus, we’ll be answering our subscribers’ questions live.

AgencyIQ attending RAPS Convergence 2025

October 7, 2025 | INDUSTRY EVENT

Alexander Gaffney, Laura DiAngelo, Amanda Conti, Sebastian Godoy, Joshua Sztorc, Casey Miles, Helena Tewolde

The AgencyIQ team will be at RAPS Convergence 2025 at the David L. Lawrence Convention Center in Pittsburgh, PA — the largest annual gathering of global regulatory affairs professionals. Join us at  booth #909 to connect with our experts, explore the AgencyIQ platform, and see how we help life sciences organizations stay ahead of regulatory change.

AgencyIQ Food Update: Analyzing The New Make America Healthy Again Strategy

August 19, 2025 | AVAILABLE ON-DEMAND

Alexander Gaffney, Laura DiAngelo, Jared Rothstein, Julia John

The Trump Administration’s Make America Healthy Again (MAHA) Strategy is due to be published on August 12, and is expected to have broad impacts on the foods, life sciences, and chemicals policy landscapes.

Join AgencyIQ’s regulatory experts for a lively, informative and actionable webinar focused on what the strategy, and underlying regulatory landscape, means for the life sciences, foods, and chemicals industries. We’ll discuss what the report says, key take-aways for industry stakeholders, potential future actions, and limitations of the report’s findings. We’ll also be available to answer your questions live.

AgencyIQ Regulatory Update: What Makary’s ‘New FDA’ is Up To

July 22, 2025 | AVAILABLE ON-DEMAND

Alexander Gaffney, Laura DiAngelo

After a slow start to the year, the FDA is starting to catch its stride again, publishing new guidance documents, engaging in policymaking, and showing signs of developing new regulatory approaches in several key product areas.

Join AgencyIQ’s regulatory experts for a lively, informative and actionable webinar focused on what the FDA has recently done – and will do next – related to the regulation of pharmaceuticals, biologics, medical devices and diagnostics. We’ll discuss the latest guidance, policies, major actions, trends, forecasted actions and political developments that matter to life sciences regulatory professionals.

As always, we will answer questions asked by our live audience.

FDA Regulatory Update: What Makary’s “New FDA” means for the life sciences industry

June 24, 2025 | AVAILABLE ON-DEMAND

Alexander Gaffney, Laura DiAngelo

Following months of upheaval during the transition to the Trump administration, the life sciences industry and the FDA are facing a different regulatory and policymaking landscape with new leadership, new directives from the White House and a new direction for regulators – and Commissioner Makary’s regulatory philosophy is starting to take shape.

AgencyIQ by POLITICO is keeping close track of these fast-moving changes and developments. In this lively, fast paced webinar we will provide in-depth explanations of how FDA policies have been impacted so far, what we’re expecting to happen next, analysis of important staffing changes, and emerging trends and policies.

AgencyIQ’s regulatory policy and intelligence experts will also be on-hand to answer your questions live.

AgencyIQ attending DIA 2025 Global Annual Meeting

June 15, 2025 | INDUSTRY EVENT

Alexander Gaffney, Casey Miles, Joshua Sztorc, Rachel Gartlan, Laura DiAngelo, Amanda Conti

The AgencyIQ Team will be attending the DIA 2025 Global Annual Meeting, at the Walter E. Washington Convention Center in Washington, DC. The conference will be covering the most pressing topics in the life sciences field, discuss innovative solutions, and provide networking opportunities. The AgencyIQ Team will be attending sessions as well exhibiting at booth #1909.

FDA Regulatory Update: What the Trump administration’s regulatory (and deregulatory) agenda means for FDA policy

May 28, 2025 | AVAILABLE ON-DEMAND

Alexander Gaffney, Laura DiAngelo

Following months of upheaval during the transition to the Trump administration, the life sciences industry and the FDA are facing a different regulatory and policymaking landscape with new leadership, new directives from the White House and a new direction for regulators.

What do life sciences regulatory professionals need to know about what has happened – and what will happen next? Join AgencyIQ for this fast-paced, lively and actionable webinar where we covered what has happened and what challenges are next for the FDA and the life sciences industry.

FDA Regulatory Update: What the destruction of the FDA as we know it means for medical product regulation

April 22, 2025 | AVAILABLE ON-DEMAND

Alexander Gaffney, Laura DiAngelo

The FDA has just endured one of the most turbulent periods in its history. Thousands of staff have been laid off. A new commissioner leads the agency. A major reorganization looms. New political pressures are being felt. Its user fee programs face potential collapse.

What do life sciences regulatory professionals need to know about what has happened – and what will happen next?

Join AgencyIQ for this fast-paced, lively and actionable webinar where we covered what has happened and what challenges are next for the FDA and the life sciences industry.

FDA Regulatory Update: How the Trump administration is affecting the FDA

March 25, 2025 | AVAILABLE ON-DEMAND

Alexander Gaffney, Laura DiAngelo

It has been two months since the start of the Trump administration, and deregulatory and downsizing efforts are starting to have effects on the FDA and the life sciences industry it regulates. Where do things go from here?

Join AgencyIQ’s regulatory experts for an informative, fast-paced, lively and actionable webinar focused on how the new Trump administration continues to affect health care product regulation.

We provided in-depth explanations of how FDA policies have been impacted so far, what we’re expecting to happen next, analysis of important staffing changes, and emerging trends and policies. We’ll also have a preview of what we expect from the FDA’s new commissioner, Marty Makary.

AgencyIQ’s regulatory policy and intelligence experts will also be on-hand to answer your questions live.

U.S. and EU Chemicals Regulatory Update: A Road of Twists and Unknowns

March 4, 2025 | AVAILABLE ON-DEMAND

Scott Stephens, Julia John, Xiaolu Wang

As expected, chemicals policy has taken a turn in 2025 under Donald Trump’s administration in the U.S. and Ursula von der Leyen’s new commission in the EU.

Join AgencyIQ by POLITICO regulatory analysts, Xiaolu Wang and Scott Stephens, and editor, Julia John, for an informative discussion about where chemical regulations may be headed on both sides of the Atlantic based on what we’ve seen in the first months of the year. Tune in to learn more about how companies can prepare to face the uncertainties ahead.

U.S. topics include executive orders relevant to chemicals policy, congressional and legal challenges to Biden-era chemical rules, and developments in state-level chemical regulations in major jurisdictions like California. For the EU, we examine the status of the Commission’s long-awaited proposal to revise REACH, as well as ECHA’s work to fulfill its new obligations under the recent CLP revision and Packaging and Packaging Waste Regulation (PPWR).

FDA Regulatory Update: How the Trump Administration’s policies are affecting the FDA

February 25, 2025 | AVAILABLE ON-DEMAND

Alexander Gaffney, Laura DiAngelo

The regulatory environment is in the midst of a period of transformative change, with major restrictions on regulation, staff changes, budget cuts and other developments that are set to have extraordinary impacts on the FDA’s regulation of the life sciences sector.

AgencyIQ by POLITICO is keeping close track of these fast-moving changes and developments. During this webinar we provided in-depth explanations of how FDA policies have been impacted so far, what we’re expecting to happen next, analysis of important staffing changes, and emerging trends and policies.

FDA Regulatory Update: Unpacking FDA’s new policies and the early days of the Trump administration

January 28, 2025 | AVAILABLE ON-DEMAND

Alexander Gaffney, Laura DiAngelo

The FDA is off to a fast start to 2025, with a blizzard of new guidance, new policies, and major staffing changes that will have significant impacts for regulated industry in 2025.

This lively, fast paced webinar will provide in-depth explanations of key FDA guidance documents, analysis of important staffing changes, and updates on new policies emerging from the administration of President Donald Trump. AgencyIQ’s regulatory policy and intelligence experts will also be on-hand to answer your questions live.